政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/38429
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  全文笔数/总笔数 : 113822/144841 (79%)
造访人次 : 51789555      在线人数 : 452
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    请使用永久网址来引用或连结此文件: https://nccur.lib.nccu.edu.tw/handle/140.119/38429


    题名: 實驗室自動化系統導入檢驗試劑市場之評估及作法
    Introduce laboratory automation system into Taiwan IVD (in vitro diagnostics) market
    作者: 邱禎祥
    Chiu, Jack
    贡献者: 何小台
    Ho, Chester
    邱禎祥
    Chiu, Jack
    关键词: 自動化系統
    日期: 2009
    上传时间: 2010-06-15 16:24:53 (UTC+8)
    摘要: 實驗室自動化系統導入檢驗試劑市場之評估及作法
    Hospital laboratories in Taiwan are confronted by the cost and quality challenges as the overall healthcarec environments are getting more rigorous. Introducing automation solution to the laboratory is one of the best ways to lower costs and improve quality of laboratory operation. Siemens Healthcare Diagnostics (SHD) is planning to launch Laboratory Automation System (LAS) in Taiwan market to address customer demand. Moreover SHD can further extend the business coverage by the lab integration while pursing automation.
    SHD identified non-public medical centers as LAS target market by considering the relative bigger market share and more flexible procurement process. As the prospects are limited at around 20 hospitals, the sales and promotion strategy will be on project based to custom-made our solution to individual hospital. SHD will not treat LAS product line as a revenue generator. Instead the LAS product is the integration tool for SHD to further extend the business in the lab. SHD will maintain current distribution channel and corporately promote the new product along with the exclusive distributor. However SHD intends to invest more on marketing and sales headcount in the middle term to ensure high customer satisfaction among these VIP accounts.
    The sales goal of this new product launch is to achieve one unit LAS installation in the first year and two units in year 2 to 5 in a row. CAGR of this new product line will be at 44.15% during the first 5 years.
    1 Company Overview………………………………………………………1
    1.1 Description………………………………………………………………..1
    1.2 Image Objectives…………………...……………………...……….……..2
    1.3 SWOT Analysis……………………………………………………….…..3
    1.4 The Future……………………………….………………………….……..7
    2 The Market………………………………………………..………………8
    2.1 Description…………………………………..………………….....………8
    2.1.1 Introduction of IVD Market………………………………………….……8
    2.1.2 Taiwan IVD Market Status……………………………….………………10
    2.1.3 Trend of Laboratory Automation…………………………………………11
    2.2 Market Segmentation………………..………………………...…………12
    2.2.1 Target Market…………………………………………..…………………12
    2.2.2 Segment Size………………………………………………………...……13
    2.3 Prospects………………………………………………….………………14
    2.3.1 Objectives…………………………………………………………………14
    2.3.2 Decision Making…………………………….……………………………15
    2.4 Competition………………………………………………….………...…16
    3 Marketing Strategy…………………………………………..……..……19
    3.1 Products / Services…………………………………..………………...…19
    3.1.1 Introduction of the Laboratory Workflow……...………………...………19
    3.1.2 Products/Service Details………………….………………………………21
    3.1.3 Value………………………………………………………………………26
    3.1.4 Brands……………………………………………………………….……27
    3.2 Pricing Strategy…………………………………………………………...28
    3.3 Distribution Strategy……………………………………………..…….…28
    3.4 Sales/Promotion Strategy…………………………………………………28
    3.5 Support…………………………………………………………...….……29
    4 Organization…………………………………………………………...…31
    4.1 Objectives………………………………………………………………...31
    4.2 Organization Factors……………………………………………………..31
    4.3 Personnel Plan for Laboratory Automation System Launch…………......32
    4.3.1 Marketing…………………………………………….…………………...32
    4.3.2 Business Development…………………………….……………………...33
    5 Financial Projection………………………………………………………34
    5.1 Marketing Expense………………………………………………………..34
    5.1.1 Year One Marketing Expense………………………………………......…34
    5.1.2 Year One Marketing Expense………………………………………..……36
    5.1.3 Five Year Marketing Expense………………………………………….…37
    5.2 Sales Expense………………………………………………………..……38
    5.2.1 Year One Sales Expense………………………………..…………………38
    5.2.2 Year Two Sales Expense…………………………………………….……39
    5.2.3 Five Year Sales Expense………………………………….…………....…40
    5.3 Sales Revenue………………………………………………….….…..….41
    5.3.1 Year One Sales Revenue…………………………………..……….…..…41
    5.3.2 Year Two Sales Revenue…………………………………..…………...…42
    5.3.3 Five Year sales Revenue………………………………….................……43
    6 Charts……………………………………………………………….……44
    6.1 Revenue per Sales Person, Year One………………………………….…44
    6.2 Revenue per Sales Person, Year Two……………………………….……44
    6.3 Revenue per Sales Person, Five Year……………………………….……45
    6.4 Revenue vs Marketing Expense…………………………………….……45
    6.5 Revenue vs Sales Expense………………………………………….……46
    6.6 Revenue vs Marketing & Sales Expense…………………………...……46
    7 Reference…………………………………………………………...……47
    參考文獻: 1. Reference.
    【1】 Hickey D. (2007). Full service diagnostics. The coming convergence of imaging, informatics and in vitro diagnostics. Executive War College; Miami, FL: May 10, 2007.
    【2】 American Society for Clinical Laboratory Science (2005). Value of clinical laboratory services in health care. Retrieved January 6, 2010, from the World Wide Web: http://www.ascls.org/position/ValueCLS.asp
    【3】 Lab Tests Online (2008). Where lab tests are performed: in a hospital. Retrieved January 6, 2010, from the World Wide Web: www.labtestsonline.org/lab/labtypes-4.html.
    【4】 Clearstate Pte. Ltd (2008). Gateway market tracker: The gateway database. Retrieved January 5, 2010, from the World Wide Web: http://clearstate.net/gateway/
    【5】 行政院衛生署 (民97年). 表62醫院醫檢人員數─按評鑑等級別及權屬別分. 民99年1月7日，取自： http://www.doh.gov.tw/CHT2006/DisplayStatisticFile.aspx?d=72418
    【6】 College of American Pathologists (2009). Accreditation and Laboratory Improvement. Retrieved January 5, 2010, from the World Wide Web: http://www.cap.org/apps/cap.portal?_nfpb=true&_pageLabel=accreditation
    【7】 行政院衛生署中央建康保險局 (2009). 維持健康保險財務平衡的支付制:您瞭解總額支付制度嗎? 民99年1月7日，取自：http://www.nhi.gov.tw/webdata/webdata.asp?menu=6&menu_id=168&webdata_id=1080&WD_ID=
    【8】 WASHINGTON G-2 REPORTS (2004). UBS Survey Says Beckman Leads in Automation. Diagnostic Testing & Technology Report. Retrieved January 6, 2010, from the World Wide Web: http://www.g2reports.com/issues/DTTR/2004_10/
    描述: 碩士
    國立政治大學
    國際經營管理碩士班(IMBA)
    94933009
    98
    資料來源: http://thesis.lib.nccu.edu.tw/record/#G0094933009
    数据类型: thesis
    显示于类别:[國際經營管理英語碩士學程IMBA] 學位論文

    文件中的档案:

    档案 大小格式浏览次数
    index.html0KbHTML2504检视/开启


    在政大典藏中所有的数据项都受到原著作权保护.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈